PROGENICS PHARMACEUTICALS INC·4

Apr 8, 3:58 PM ET

Baker Mark Robert 4

4 · PROGENICS PHARMACEUTICALS INC · Filed Apr 8, 2013

Insider Transaction Report

Form 4
Period: 2013-04-04
Baker Mark Robert
General Counsel
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2013-04-04$5.03/sh+120,000$603,600120,000 total
    Exercise: $5.03Exp: 2023-04-04Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]The stock options become exercisable in three equal annual installments, commencing one year from the grant date.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT